Xenetic Biosciences (XBIO) Misses Q1 EPS by 13c

Xenetic Biosciences (NASDAQ: XBIO) reported Q1 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
• Faraday Future says it regained Nasdaq compliance after equity shortfall